Publikationen von Barbara Breitenstein

Rosenblum, Y.; Weber, F. D.; Rak, M.; Zavecz, Z.; Kunath, N.; Breitenstein, B.; Rasch, B.; Zeising, M.; Uhr, M.; Steiger, A. et al.; Dresler, M.: Sustained polyphasic sleep restriction abolishes human growth hormone release. SLEEP 47 (2), zsad321 (2024)

Breitenstein, B.; Scheuer, S.; Brückl, T. M.; Meyer, J.; Ising, M.; Uhr, M.; Holsboer, F.: Association of ABCB1 gene variants, plasma antidepressant concentration, and treatment response: Results from a randomized clinical study. JOURNAL OF PSYCHIATRIC RESEARCH 73, S. 86 - 95 (2016)

Bosch, O. G.; Breitenstein, B.: Biomarker in der Depressionsbehandlung: mehr als nur Worte? [Biomarkers in clinical depression treatment: more than words?]. ZEITSCHRIFT FUR PSYCHIATRIE PSYCHOLOGIE UND PSYCHOTHERAPIE 63 (4), S. 217 - 232 (2015)

Breitenstein, B.; Brückl, T. M.; Ising, M.; Müller-Myhsok, B.; Holsboer, F.; Czamara, D.: ABCB1 gene variants and antidepressant treatment outcome: A meta-analysis. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS 168 (4), S. 274 - 283 (2015)

Breitenstein, B.; Scheuer, S.; Holsboer, F.: Are there meaningful biomarkers of treatment response for depression? DRUG DISCOVERY TODAY 19 (5), S. 539 - 561 (2014)

Breitenstein, B.; Scheuer, S.; Pfister, H.; Uhr, M.; Lucae, S.; Holsboer, F.; Ising, M.; Brückl, T. M.: The clinical application of ABCB1 genotyping in antidepressant treatment: a pilot study. CNS SPECTRUMS 19 (2), S. 165 - 175 (2014)

Breitenstein, B.; Brueckl, T. M.; Nickel, T.; Ising, M.; Holsboer, F.: ABCB1 Genotyping Informs the Clinician About Adequacy of Antidepressant Dosing. In BIOLOGICAL PSYCHIATRY, 75 (9), S. 23S - 23S. 69th Annual Scientific Convention and Meeting of the Society-of-Biological-Psychiatry, New York, NY, 08. Mai 2014 - 10. Mai 2014. Elsevier Science Inc., New York, NY, USA (2014)